An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrixâ¢) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children

Article ID	Journal	Published Year	Pages	File Type
10969734	Vaccine	2012	7 Pages	PDF

Abstract

âº This study evaluated co-administration of DTaP-IPV and MMR with varicella vaccine in 4-6 year olds. âº Varicella vaccine with DTaP-IPV and MMR did not impact immunogenicity of DTaP-IPV. âº Co-administration of varicella vaccine with DTaP-IPV and MMR was well tolerated. âº Results support co-administration of DTaP-IPV, MMR, and varicella vaccines in 4-6-year-olds.

Keywords

MMR GSK SAE Measles mumps rubella Vaccine ATP standard deviation according-to-protocol booster Pertussis Serious adverse event confidence interval Measles–mumps–rubella vaccine Varicella vaccine poliomyelitis